Navigation Links
George Golumbeski, President of GRAIL, Inc. to Deliver Keynote at BD Boston 2018
Date:7/26/2018

Boston Biotech Conferences will host BD Boston, an invitation-only, off-the-record meeting for C-level biopharma executives on September 4, 2018 at The Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides an opportunity for industry leaders to leverage insight from real-life business development experiences and dissect the most relevant deals in biotech.

George Golumbeski recently joined GRAIL with more than 25 years of experience in the biotechnology industry. He currently serves on the Board of Directors at KSQ Therapeutics, Carrick Therapeutics, Enanta Pharmaceuticals, and MorphoSys. Dr. Golumbeski was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation.

To attend, please register here.

ABOUT BOSTON BIOTECH CONFERENCES:
Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, forge partnerships and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com

Contact:
Boston Biotech Conferences
Suzanne Carroll: suzanne@bbbiotechconference.com
Nicole Hayes: nicole@bbbiotechconference.com

Read the full story at https://www.prweb.com/releases/george_golumbeski_president_of_grail_inc_to_deliver_keynote_at_bd_boston_2018/prweb15648780.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. The American Society for Microbiology honors George L. Drusano
2. Stephen Zarrilli Named President & CEO of University City Science Center
3. How to Fix President Trumps "Travel Ban" Executive Order; a 9/11 Commission Counsels Perspective
4. Texas Biomed Names Larry Schlesinger, M.D. As President/CEO
5. Genpact Executive Jeff Schultz Joins QStride As Vice President of National Business Development
6. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables
9. Colombian president honors WCS president and CEO Dr. Cristián Samper
10. NXT-ID, Inc. Names Vice-President and Chief Financial Officer
11. JAX President and CEO Edison Liu, M.D., to receive Chen Award from HUGO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2019)... ... 07, 2019 , ... Murrieta Genomics , the genomic sequencing business incubator, ... by University of California Riverside’s EPIC SBDC focused on research funding by U.S. Small ... Tuesday, March 17, 2019. The location is the Highlander Union Building, Room 302 South ...
(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio ... – exciting compounds for scientists studying GPCR and DREADD signalling. Hello Bio has ... National Institute of Neurological Disorders and Stroke, both institutes of the National Institutes ...
(Date:2/27/2019)... ... ... Circulomics is launching the Short Read Eliminator Kit to perform size ... , This kit enhances long-read sequencing read lengths by using size selective precipitation to ... recovered with high efficiency. Short DNA up to 25 kb in length are progressively ...
Breaking Biology News(10 mins):
(Date:3/15/2019)... ... March 15, 2019 , ... ... in American Process Inc. and affiliate companies including AVAPCO LLC and API ... Michigan, the Thomaston Biorefinery and R&D center in Thomaston, Georgia, operations, research, ...
(Date:3/14/2019)... ... March 13, 2019 , ... Murrieta Genomics , the genomic ... industry specific and broader business experience to bear as genomic sequencing startups build their ... the knowledge and expertise that our Advisory Board brings to the table. Many of ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many ... will learn how to use the information they have from the protocol and clinical ... randomization scheme is properly designed and set up to ensure flawless execution. As clinical ...
(Date:3/5/2019)... ... 2019 , ... Modality Solutions, an Inc. Verified Company, ... network experts, and experienced integrated staffing professionals. , Upon receiving Modality ... program, Inc. editors independently reviewed the Houston-based cold chain management company to validate ...
Breaking Biology Technology: